The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation (Q21195756)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation	scientific article

Statements

scholarly article

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation (English)

0 references

0 references

0 references

pulmonary fibrosis

1 reference

based on heuristic

inferred from title

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

idiopathic pulmonary fibrosis

1 reference

based on heuristic

inferred from title

Claudia Bausewein

9

object named as

Claudia Bausewein

author given names

Claudia

author last names

Bausewein

1 reference

Dimensions Publication ID

17 August 2022

Jillian Leigh Colquitt

3

object named as

Jill L Colquitt

author given names

Jill L

author last names

Colquitt

1 reference

Dimensions Publication ID

17 August 2022

1

object named as

Emma Loveman

author given names

Emma

author last names

Loveman

1 reference

Dimensions Publication ID

17 August 2022

object named as

David A Scott

4

author given names

David A

author last names

Scott

1 reference

Dimensions Publication ID

17 August 2022

author name string

Vicky R Copley

2

author given names

Vicky R

author last names

Copley

1 reference

Dimensions Publication ID

17 August 2022

Andy J Clegg

5

author given names

Andy J

author last names

Clegg

1 reference

Dimensions Publication ID

17 August 2022

Jeremy Jones

6

author given names

Jeremy

author last names

Jones

1 reference

Dimensions Publication ID

17 August 2022

Katherine M A O'Reilly

7

author given names

Katherine MA

author last names

O’Reilly

1 reference

Dimensions Publication ID

17 August 2022

Sally Singh

8

author given names

Sally

author last names

Singh

1 reference

Dimensions Publication ID

17 August 2022

Athol Wells

10

author given names

Athol

author last names

Wells

1 reference

Dimensions Publication ID

17 August 2022

language of work or name

0 references

publication date

2014

0 references

BMC pharmacology & toxicology

1 reference

15

0 references

1

0 references

63

0 references

Idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

19 March 2017

Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

19 March 2017

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

19 March 2017

The rising incidence of idiopathic pulmonary fibrosis in the U.K

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

19 March 2017

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

19 March 2017

Pirfenidone in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

19 March 2017

High-dose acetylcysteine in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

19 March 2017

Demystifying trial networks and network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Incidence and prevalence of idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

A simple method for converting an odds ratio to effect size for use in meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4247619

12 September 2017

The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012.

1 reference

https://api.crossref.org/works/10.1186%2F2050-6511-15-63

21 January 2018

Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1186%2F2050-6511-15-63

21 January 2018

Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1186%2F2050-6511-15-63

21 January 2018

Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1186%2F2050-6511-15-63

21 January 2018

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1186%2F2050-6511-15-63

21 January 2018

Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1186%2F2050-6511-15-63

21 January 2018

Assessment of quality of life in lung transplantation using a simple generic tool

1 reference

https://api.crossref.org/works/10.1186%2F2050-6511-15-63

21 January 2018

[Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis with inspiratory muscle training]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25410822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25410822

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/2050-6511-15-63

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21195756&oldid=2176663644"